Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study

被引:176
作者
Ramiro, Sofia [1 ,2 ]
Stolwijk, Carmen [3 ,4 ]
van Tubergen, Astrid [3 ,4 ]
van der Heijde, Desiree [5 ]
Dougados, Maxime [6 ]
van den Bosch, Filip [7 ]
Landewe, Robert [1 ,8 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Clin Immunol & Rheumatol, NL-1100 DD Amsterdam, Netherlands
[2] Hosp Garcia de Orta, Dept Rheumatol, Almada, Portugal
[3] Maastricht Univ, Med Ctr, Dept Med, Div Rheumatol, Maastricht, Netherlands
[4] Maastricht Univ, Sch Publ Hlth & Primary Care CAPHRI, Maastricht, Netherlands
[5] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands
[6] Paris Descartes Univ, Cochin Hosp, Rheumatol Dept B, Paris, France
[7] Univ Ghent, Dept Rheumatol, B-9000 Ghent, Belgium
[8] Atrium Med Ctr, Dept Rheumatol, Heerlen, Netherlands
关键词
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; AXIAL SPONDYLOARTHRITIS; PROGRESSION; SYNDESMOPHYTES; THERAPY; SPINE;
D O I
10.1136/annrheumdis-2013-204055
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To describe the evolution of radiographic abnormalities of the spine in patients with ankylosing spondylitis (AS). Methods Patients with AS were followed prospectively with 2 yearly radiographs for 12 years. The modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) was scored by two readers (R1 and R2). New syndesmophytes at uninvolved vertebral corners were computed. Radiographic progression was investigated using generalised estimating equations. Results 809 radiographs (presenting 520 at 2 yearly intervals) from 186 patients (70% men, mean age 43 (SD 12) years, mean 20 (SD 12) years since symptom onset and 83% HLA-B27 positive) were included. Mean mSASSS at baseline was 11.6 (16.2). While the course of progression in individual patients was highly variable, and still occurred in patients with decades of symptom duration, mean 2 year progression was 2.0 (3.5) mSASSS units. Over the entire follow-up, at least one new syndesmophyte was found in 55% (R1) and 63% (R2) of patients (38% (R1) and 39% (R2) of all intervals). In 24% of patients (39% of intervals), there was no progression. A progression >= 5 mSASSS units occurred in 22% of patients (or in 12% of intervals). At the group level, a linear time course model fitted the data best, with a constant rate over the entire 12 year interval of 0.98 mSASSS units/year. Radiographic progression occurred significantly faster in men, in HLA-B27 positive patients and in patients with a baseline mSASSS >= 10. Conclusions Long term radiographic progression in AS is highly variable in the individual patient, more severe in HLA-B27 positive men and still occurs after decades of disease. At the group level, however, progression in AS follows an approximately linear course.
引用
收藏
页码:52 / 59
页数:8
相关论文
共 29 条
[1]   Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes [J].
Baraliakos, X. ;
Listing, J. ;
Rudwaleit, M. ;
Haibel, H. ;
Brandt, J. ;
Sieper, J. ;
Braun, J. .
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (07) :910-915
[2]   Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis [J].
Baraliakos, Xenofon ;
Haibel, Hildrun ;
Listing, Joachim ;
Sieper, Joachim ;
Braun, Juergen .
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (04) :710-715
[3]   The Natural Course of Radiographic Progression in Ankylosing Spondylitis - Evidence for Major Individual Variations in a Large Proportion of Patients [J].
Baraliakos, Xenofon ;
Listing, Joachim ;
von der Recke, Anna ;
Braun, Jurgen .
JOURNAL OF RHEUMATOLOGY, 2009, 36 (05) :997-1002
[4]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[5]   2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis [J].
Braun, J. ;
van den Berg, R. ;
Baraliakos, X. ;
Boehm, H. ;
Burgos-Vargas, R. ;
Collantes-Estevez, E. ;
Dagfinrud, H. ;
Dijkmans, B. ;
Dougados, M. ;
Emery, P. ;
Geher, P. ;
Hammoudeh, M. ;
Inman, R. D. ;
Jongkees, M. ;
Khan, M. A. ;
Kiltz, U. ;
Kvien, T. K. ;
Leirisalo-Repo, M. ;
Maksymowych, W. P. ;
Olivieri, I. ;
Pavelka, K. ;
Sieper, J. ;
Stanislawska-Biernat, E. ;
Wendling, D. ;
Ozgocmen, S. ;
van Drogen, C. ;
van Royen, B. J. ;
van der Heijde, D. .
ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (06) :896-904
[6]  
Brophy S, 2002, J RHEUMATOL, V29, P1236
[7]   Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change [J].
Bruynesteyn, K ;
Boers, M ;
Kostense, P ;
van der Linden, S ;
van der Heijde, D .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (02) :179-182
[8]   Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system [J].
Creemers, MCW ;
Franssen, MJAM ;
van't Hof, MA ;
Gribnau, FWJ ;
van de Putte, LBA ;
van Riel, PLCM .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (01) :127-129
[9]   ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis [J].
Dougados, Maxime ;
Simon, Paternotte ;
Braun, Juergen ;
Burgos-Vargas, Ruben ;
Maksymowych, Walter P. ;
Sieper, Joachim ;
van der Heijde, Desiree .
ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (02) :249-251
[10]   Continuous NSAID use reverts the effects of in ammation on radiographic progression in patients with ankylosing spondylitis [J].
Kroon, Feline ;
Landewe, Robert ;
Dougados, Maxime ;
van der Heijde, Desiree .
ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (10) :1623-1629